Advanced understanding of cancer progression in circulating tumor cells using multiplexed imaging technology

Advanced understanding of cancer progression in circulating tumor cells using multiplexed imaging technology

Applied Spectral Imaging (Israel), MetaGene and QIMR Berghofer Medical Research Institute (Australia) have developed a multiplexed fluorescent imaging system to advance the understanding of disease progression in tissue, liquid biopsy and circulating tumor cells. The system offers a cost-effective, rapid, integrated solution for up to 24-plex* MIF analysis.

Original Research Article: 

Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch
Front. Immunol., 16 June 2020 | https://doi.org/10.3389/fimmu.2020.01228

Contact us on 1800 788 498 or admin@metagene.com.au for more information on Applied Spectral Imaging technology, or visit https://spectral-imaging.com/

*Dependent on Filter and Module selection.

No Comments

Post A Comment